Drug Companies Need to Push for Medication Adherence
November 27, 2012
Faced with losses totally over $185 billion annually in revenue due to patient non-compliance, pharmaceutical companies must find ways to keep patients on their medicines. Studies show that reduced costs – even to seemingly motivated individuals – does little at influencing medical adherence. Read this article from Forbes.com to learn more about this study from Capgemini and see how RxAnte is positioned to help pharmaceutical companies face medication adherence.